About this episode

The episode reviews a Court of Appeal decision regarding provisional measures and a Preliminary Injunction against Viatris Santé's marketing of a generic drug.

The Court of Appeal (CoA) has overturned the Paris LD’s refusal of provisional measures and granted a Preliminary Injunction (PI) preventing Viatris Santé from marketing its fampridine generic (which is for the improvement of walking speed in adult patients with MS) in France until expiry of Merz’s SPC in July 2026. Listen to Aida Tohala's review of this decision in this episode of You, Me and the UPC: Case by case. If you have any feedback, questions, or comments, please email us at upcpodca...

People in this episode

Host: Aida Tohala

Topics covered

• provisional measures
• court decisions
• intellectual property
• generic drugs
• legal proceedings
• injunctions

Mentioned in this episode

Organizations: Viatris Santé, Merz

Products: fampridine

Places: France

More episodes of You, me & the UPC

• Case by Case | Düsseldorf Local Division rejects request for preliminary injunction amid doubts over infringement and urgency · May 29, 2026 · 5 min
• Case by Case | Munich Local Division confirms that FRAND security cannot be relied on to resist security for costs · May 29, 2026 · 4 min
• Case by Case | Düsseldorf Local Division rejects expert bias challenge and upholds ex parte inspection regime · May 22, 2026 · 4 min
• Case by Case | The Hague Local Division dismisses Stratasys Preliminary Injunction application following narrow claim construction on purge towers · May 15, 2026 · 3 min
• Case by Case | Mannheim Local Division grants Nokia ex parte anti-suit injunction in relation to Chinese interim licence application · May 15, 2026 · 3 min

Explore listener stats, chart rankings, contacts and more on the You, me & the UPC podcast page.